• Startup Pulse
    NeuMe Neurotech secures an undisclosed amount in funding from IvyCap Ventures India Endowment Fund VitusCare secures US$3 million in Series B funding from Liberty Ridge Capital, HDFC Bank, Equentis, NAFA Capital Advisors, existing investors and angels. Humyn Labs raises $47 million in a Series A round, comprising $26 million in equity led by Accel and $21 million in venture debt led by Lighthouse Canton JohnAIC raises $1.9 million in a pre-seed funding round led by Crane Venture Partners, with participation from Neon Fund. Dreamteam Raises $53 Million to Take on Salesforce and HubSpot With AI Coworkers Deeptech Aerospace Startup Tessat Space Raises ₹1 Crore in Angel Funding Round from Xylapay Morsa raises $1.5 million in a pre-seed funding round led by Jackson Square Ventures, with participation from the a16z Scout Fund. Kutlerri.ai raises $4 million from Narahari Investments. JSW Ventures completes the first close of Fund III, with JSW Family Office as anchor investor. Desible.ai raises ₹32 crore in a funding round led by Prime Venture Partners, with participation from Invention Engine. NeuMe Neurotech secures an undisclosed amount in funding from IvyCap Ventures India Endowment Fund VitusCare secures US$3 million in Series B funding from Liberty Ridge Capital, HDFC Bank, Equentis, NAFA Capital Advisors, existing investors and angels. Humyn Labs raises $47 million in a Series A round, comprising $26 million in equity led by Accel and $21 million in venture debt led by Lighthouse Canton JohnAIC raises $1.9 million in a pre-seed funding round led by Crane Venture Partners, with participation from Neon Fund. Dreamteam Raises $53 Million to Take on Salesforce and HubSpot With AI Coworkers Deeptech Aerospace Startup Tessat Space Raises ₹1 Crore in Angel Funding Round from Xylapay Morsa raises $1.5 million in a pre-seed funding round led by Jackson Square Ventures, with participation from the a16z Scout Fund. Kutlerri.ai raises $4 million from Narahari Investments. JSW Ventures completes the first close of Fund III, with JSW Family Office as anchor investor. Desible.ai raises ₹32 crore in a funding round led by Prime Venture Partners, with participation from Invention Engine.
  • IITF 2026: Bionic Ears, Cancer-Fighting Cells and AI Medicines. India’s Startups Are Thinking Big

    IITF 2026

    New Delhi: From AI-powered disease detection and CAR-T cancer treatments to bionic ear implants and regenerative medicine, 10 Indian startups are showcasing homegrown pharmaceutical and medical technology innovations at IITF 2026 in New Delhi.

    The innovations are being presented at the 45th India International Trade Fair (IITF), which opened at Bharat Mandapam on November 19.

    The Department of Pharmaceuticals, under the Ministry of Chemicals and Fertilizers, has sponsored stalls for the startups under the ‘Hall of Inspiration’ initiative in collaboration with the Department for Promotion of Industry and Internal Trade (DPIIT). The exhibition will continue until November 23.

    The participating companies are supported under the government’s Promotion of Research and Innovation in Pharma-MedTech (PRIP) scheme, which aims to strengthen research, product development and innovation in India’s pharmaceutical and medical technology sectors.

    IITF 2026 Showcases AI Diagnostics and Indigenous Medical Devices

    A significant part of the showcase focuses on diagnostic technologies and medical devices designed to improve disease detection and healthcare delivery.

    The innovations include AI-powered microscopes and automated diagnostic machines, including technologies for detecting tuberculosis through genetic testing.

    Startups are also demonstrating portable blood-testing machines that can deliver blood count results within 10 minutes, alongside indigenous molecular diagnostic kits and equipment for detecting infections such as tuberculosis and COVID-19.

    In the medical device segment, the exhibition features AI-enabled bionic ear implants and rehabilitation devices for people with hearing impairments. Another innovation is a protective surgical helmet developed for doctors performing complex procedures, including hip and knee replacements.

    An implantable bone-lengthening device for limb reconstruction is also among the technologies being showcased.

    CAR-T Therapies, Gene Treatments and 3D Tumour Models on Display

    Advanced therapies form another major part of the IITF 2026 showcase, with startups presenting developments in cancer treatment and biological medicine.

    These include CAR-T cell therapies for blood cancers and gene therapies targeting inherited blood disorders. The exhibition also features 3D tumour models designed to help assess how effectively chemotherapy treatments work.

    Startups are further showcasing vaccine and biological medicine development technologies, as well as regenerative medicine solutions aimed at repairing damaged tissues and addressing conditions affecting the eyes, liver and lungs.

    AI-Designed Medicines for Obesity and Diabetes

    The participating startups are also highlighting developments in pharmaceutical research, including AI-designed oral medicines under development for obesity and diabetes.

    These innovations, alongside the diagnostic systems and advanced therapies, reflect the range of research and product development taking place across India’s emerging pharma and MedTech startup ecosystem.

    Awadhesh Kumar Choudhary, Senior Economic Advisor at the Department of Pharmaceuticals, inaugurated the Department-sponsored stalls on November 19 in the presence of senior departmental officials.

    Through its participation in IITF 2026, the Department is providing PRIP-supported startups with a platform to demonstrate their technologies, prototypes and products to visitors and industry stakeholders.

    The initiative is part of the government’s efforts to strengthen indigenous pharmaceutical and medical technology development and build a more competitive, innovation-driven healthcare ecosystem in India.

    Author

    • Salil Urunkar

      Salil Urunkar is a senior journalist and the editorial mind behind Sahyadri Startups. With years of experience covering Pune’s entrepreneurial rise, he’s passionate about telling the real stories of founders, disruptors, and game-changers.

    Back to top